Actively Recruiting
Accelerated rTMS in Hospitalized Patients With OCD: a Feasibility and Mechanistic Study
Led by University Hospital, Ghent · Updated on 2025-08-22
60
Participants Needed
1
Research Sites
292 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Ghent
Lead Sponsor
U
University Ghent
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study investigates a new treatment approach for Obsessive-Compulsive Disorder (OCD), a condition characterized by unwanted repetitive thoughts and behaviors. The goal is to determine whether combining specialized inpatient care with repetitive Transcranial Magnetic Stimulation (rTMS) is feasible, well-tolerated, and effective. rTMS is a non-invasive procedure that uses magnetic pulses to stimulate specific areas of the brain. In this study, two types of rTMS will be tested: deep TMS (dTMS) and intermittent theta burst stimulation (iTBS). Both treatments will be administered using an accelerated protocol, involving multiple sessions per day over a two-week period. Patients will be randomly assigned to one of three groups: two groups will receive either dTMS or iTBS combined with Exposure and Response Prevention (ERP), a recognized psychotherapy for OCD; the third group will receive only ERP without rTMS. Participant Requirements next to treatment: Questionnaires: Patients will complete surveys before the treatment period, immediately after the treatment period, and four weeks post-treatment. MRI \& EEG: Patients will undergo brain imaging (MRI) and brain wave (EEG) recordings before and after the treatment period. Adverse Effects Diary: Patients will maintain a daily log of any side effects experienced during the treatment period. The study aims to assess the feasibility, safety, and effectiveness of this combined treatment approach and to examine its effects on underlying brain processes related to clinical outcomes.
CONDITIONS
Official Title
Accelerated rTMS in Hospitalized Patients With OCD: a Feasibility and Mechanistic Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 65
- Hospitalization for Obsessive-Compulsive Disorder (OCD)
- Participation in Exposure and Response Prevention Therapy
- Significant OCD symptoms with a Y-BOCS score of 20 or higher (moderate to severe)
You will not qualify if you...
- Current suicidal thoughts or behaviors
- Diagnosis of an active psychotic disorder
- Active substance use disorder
- Presence of a Deep Brain Stimulation (DBS) device for OCD
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UZ Gent
Ghent, Oost-Vlaanderen, Belgium, 9000
Actively Recruiting
Research Team
S
Stefanie De Smet, PhD
CONTACT
C
Chris Baeken, PhD. MD. Psychiatry
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here